​

Funding Round

Series C - Nimbus Therapeutics

Series C - Nimbus Therapeutics

Investment Firm

Overview

Nimbus Therapeutics uses computational technology to create selective small molecule therapeutics.

Announced Date

Jun 05, 2018

Funding Type

Series C

Highlights

Location

United States, North America

Social

Investor Lead

SR One

SR One

SR One is a early_stage_venture and late_stage_venture and post_ipo and private_equity and seed and venture firm.

Participant Investors

7

Investor Name
Participant InvestorSR One
Participant InvestorSchrödinger
Participant InvestorLightstone Ventures
Participant InvestorBill Gates
Participant InvestorAtlas Venture

Round Details and Background

Nimbus Therapeutics raised $65000000 on 2018-06-05 in Series C

Nimbus Therapeutics uses computational technology to create selective small molecule therapeutics.

Company Funding History

9

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Mar 19, 2015
Series B - Nimbus Therapeutics
6-43.0M
Apr 29, 2010
Seed Round - Nimbus Therapeutics
2-3.5M
Jun 28, 2011
Series A - Nimbus Therapeutics
4-24.0M
Mar 10, 2011
Seed Round - Nimbus Therapeutics
3-1.5M

Recent Activity

There is no recent news or activity for this profile.